Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M | Sales 2024 * | 129M 163M | Capitalization | 318M 398M |
---|---|---|---|---|---|
Net income 2023 | -157M -197M | Net income 2024 * | -36M -45.18M | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.78M | Net cash position 2024 * | 15.86M 19.91M | EV / Sales 2024 * | 2.33 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.88
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-2.24% | 21.93B | |
-12.15% | 22.34B | |
-5.52% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |